• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AV-TEMECULA-CT RX HERCULINK ELITE STENT SYSTEM; RENAL STENT SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AV-TEMECULA-CT RX HERCULINK ELITE STENT SYSTEM; RENAL STENT SYSTEM Back to Search Results
Catalog Number 1011504-18
Device Problems Difficult To Position (1467); Improper or Incorrect Procedure or Method (2017); Failure to Advance (2524)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 03/09/2015
Event Type  malfunction  
Event Description
It was reported that the patient underwent a procedure to treat a target lesion in the proximal mesenteric artery.The herculink elite stent delivery system was advanced to the target lesion, but was unable to cross to the target lesion.The herculink elite delivery system caught on the guide catheter during removal.A 4.5 x 20 mm non-abbott stent was used to treat the target lesion.There was no reported adverse patient effect and no clinically significant delay.There was no additional information provided.
 
Manufacturer Narrative
(b)(4).Incorrect anatomy.Evaluation summary: the device was returned, inside a non-abbott guiding catheter, for evaluation and the reported difficulty to remove was confirmed.The reported failure to cross and resistance could not be confirmed as it was based on case circumstances.Based on visual, dimensional and functional analysis of the returned device, there is no indication of a product deficiency.A review of the lot history record revealed no non-conformances.A query of the electronic complaint handling database revealed no other similar incidents reported from this lot.It was reported that the herculink elite was being used to treat the proximal mesenteric artery.It should be noted that the herculink elite stent system instructions for use states: the rx herculink elite biliary stent system is intended for palliation of malignant strictures in the biliary tree.In this case, it could not be determined if the off-label use caused or contributed to the reported difficulties.Based on the information reviewed, there is no indication of a product deficiency.
 
Manufacturer Narrative
(b)(4).It was reported that the herculink elite was being used to treat the proximal mesenteric artery.It should be noted that the herculink elite stent system instructions for use states: the rx herculink elite renal stent system is indicated for use in patients with atherosclerotic disease of the renal arteries following sub-optimal percutaneous transluminal renal angioplasty (ptra) of a de novo or restenotic atherosclerotic lesion (15 mm in length) located within 10 mm of the renal ostium and with a reference vessel diameter of 4.0 - 7.0 mm.In this case, it could not be determined if the off-label use caused or contributed to the reported difficulties.Based on the information reviewed, there is no indication of a product deficiency.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RX HERCULINK ELITE STENT SYSTEM
Type of Device
RENAL STENT SYSTEM
Manufacturer (Section D)
AV-TEMECULA-CT
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer (Section G)
ABBOTT VASCULAR, TEMECULA, CA USA REG# 2024168
abbott vascular
26531 ynez road
temecula CA 92591 462
Manufacturer Contact
connie speck
abbott vascular
26531 ynez road
temecula, CA 92591-4628
9519143996
MDR Report Key4741121
MDR Text Key5704112
Report Number2024168-2015-02446
Device Sequence Number1
Product Code NIN
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 04/06/2015
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/30/2015
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/31/2017
Device Catalogue Number1011504-18
Device Lot Number5011261
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/09/2015
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/30/2015
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/01/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE CATHETER: 6FRENCH X 55 CM IMA LAUNCHER
Patient Age87 YR
Patient Weight47
-
-